New insights into mechanisms of atrial fibrillation.
暂无分享,去创建一个
J Kautzner | J. Kautzner | P. Peichl | V. Melenovský | V Melenovský | B Aldhoon | P Peichl | B. Aldhoon
[1] A. G. Gittenberger-de Groot,et al. The role of neural crest and epicardium-derived cells in conduction system formation. , 2003, Novartis Foundation symposium.
[2] S. Nattel,et al. Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure , 2001, Circulation.
[3] Robert H. Anderson,et al. Anatomy of the Left Atrium: , 1999, Journal of cardiovascular electrophysiology.
[4] J. Goudevenos,et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. , 2005, International journal of cardiology.
[5] G Hindricks,et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease , 2004, Heart.
[6] Thomas H Everett,et al. Atrial fibrosis and the mechanisms of atrial fibrillation. , 2007, Heart rhythm.
[7] A. Tveit,et al. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. , 2007, The American journal of cardiology.
[8] M. Allessie,et al. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation , 1985 .
[9] A. Takeshita,et al. Role of Transforming Growth Factor-β1 in Cardiovascular Inflammatory Changes Induced by Chronic Inhibition of Nitric Oxide Synthesis , 2000 .
[10] M. Allessie,et al. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation? , 2005, Heart rhythm.
[11] Sander Verheule,et al. Arrhythmogenic Substrate of the Pulmonary Veins Assessed by High-Resolution Optical Mapping , 2003, Circulation.
[12] A. Takeshita,et al. Transforming Growth Factor- (cid:1) Function Blocking Prevents Myocardial Fibrosis and Diastolic Dysfunction in Pressure-Overloaded Rats , 2002 .
[13] A. Takeshita,et al. Role of transforming growth factor-beta1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. , 2000, Hypertension.
[14] H. Thaler,et al. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. , 2005, Chest.
[15] Javier Moreno,et al. Activation of Inward Rectifier Potassium Channels Accelerates Atrial Fibrillation in Humans: Evidence for a Reentrant Mechanism , 2006, Circulation.
[16] A. L. Wit,et al. Triggered activity and atrial fibrillation. , 2007, Heart rhythm.
[17] S. Nattel,et al. Effects of Antiarrhythmic Drugs on Fibrillation in the Remodeled Atrium: Insights Into the Mechanism of the Superior Efficacy of Amiodarone , 2003, Circulation.
[18] K. Becker,et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans , 2003, Experimental & Molecular Medicine.
[19] S Nattel,et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.
[20] D. Zipes,et al. Effects of selective vagal and stellate ganglion stimulation of atrial refractoriness. , 1974, Cardiovascular research.
[21] J. Towbin. Scarring in the heart--a reversible phenomenon? , 2007, The New England journal of medicine.
[22] T. Hewitson,et al. Drugs of the future: the hormone relaxin , 2007, Cellular and Molecular Life Sciences.
[23] D. Levy,et al. Pulse pressure and risk of new-onset atrial fibrillation. , 2007, JAMA.
[24] K. Stangl,et al. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. , 2000, Journal of the American College of Cardiology.
[25] D. V. Van Wagoner,et al. Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation , 2001, Circulation.
[26] Samuel Wann,et al. [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.
[27] W. Stevenson,et al. Atrial Fibrillation after Cardiac Surgery , 2001, Annals of Internal Medicine.
[28] L. Katwa,et al. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. , 1997, Journal of molecular and cellular cardiology.
[29] Bruce M Psaty,et al. Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.
[30] S Nattel,et al. Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation. , 1997, Circulation research.
[31] Stanley Nattel,et al. Mechanisms of atrial fibrillation: lessons from animal models. , 2005, Progress in cardiovascular diseases.
[32] M. Fishbein,et al. Nerve sprouting induced by radiofrequency catheter ablation in dogs. , 2004, Heart rhythm.
[33] Liming Zhang,et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties , 2003, The Journal of physiology.
[34] Douglas L. Jones,et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.
[35] M. Russo,et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.
[36] Mitsuru Yamamoto,et al. Pacing-Induced Spontaneous Activity in Myocardial Sleeves of Pulmonary Veins After Treatment With Ryanodine , 2003, Circulation.
[37] T. Doetschman,et al. TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II , 2002 .
[38] P. Box. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery:A randomized controlled trial , 2007 .
[39] J Clémenty,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.
[40] E. Gang,et al. Radiofrequency catheter ablation and nerve growth factor concentration in humans. , 2006, Heart rhythm.
[41] J. Keaney. Oxidative stress and the vascular wall: NADPH oxidases take center stage. , 2005, Circulation.
[42] Sebastian Wachsmann-Hogiu,et al. Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction: implications for catheter ablation of atrial-pulmonary vein junction. , 2006, Journal of the American College of Cardiology.
[43] W. Evans,et al. LONE AURICULAR FIBRILLATION , 1954, British heart journal.
[44] K. Nademanee,et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. , 2004, Journal of the American College of Cardiology.
[45] W. Rheinboldt,et al. A COMPUTER MODEL OF ATRIAL FIBRILLATION. , 1964, American heart journal.
[46] R. Sheppard,et al. Fibrosis in heart disease: understanding the role of transforming growth factor‐β1 in cardiomyopathy, valvular disease and arrhythmia , 2006, Immunology.
[47] N. Mochizuki,et al. Angiotensin II Type 1 Receptor Blocker Prevents Atrial Structural Remodeling in Rats with Hypertension Induced by Chronic Nitric Oxide Inhibition , 2006, Hypertension Research.
[48] M. Allessie,et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.
[49] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.
[50] Steven V. Ley,et al. Targeting C-reactive protein for the treatment of cardiovascular disease , 2006, Nature.
[51] E. Fleck,et al. Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. , 2000, Cardiovascular research.
[52] C. White,et al. The Impact of Suppressing the Renin‐Angiotensin System on Atrial Fibrillation , 2006, Journal of clinical pharmacology.
[53] M. Di Nisio,et al. Increased Expression of Transforming Growth Factor-β1 as a Stabilizing Factor in Human Atherosclerotic Plaques , 2004, Stroke.
[54] K. Channon,et al. A Myocardial Nox2 Containing NAD(P)H Oxidase Contributes to Oxidative Stress in Human Atrial Fibrillation , 2003, Circulation research.
[55] Ralph Lazzara,et al. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. , 2005, Journal of the American College of Cardiology.
[56] C. Hack,et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. , 1997, Circulation.
[57] C. Pandozi,et al. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. , 1998, Circulation.
[58] J. Olgin,et al. Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure , 2006, Circulation.
[59] J. Dernellis,et al. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. , 2004, European heart journal.
[60] S. Nattel,et al. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. , 2007, Cardiovascular research.
[61] M. Chung,et al. Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation , 2001, Circulation research.
[62] D. Hopkins,et al. Gross and microscopic anatomy of the human intrinsic cardiac nervous system , 1997, The Anatomical record.
[63] Sander Verheule,et al. Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.
[64] S Nattel,et al. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model. , 1999, Cardiovascular research.
[65] H. Wellens,et al. Philippe Coumel: a founding father of modern arrhythmology. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[66] S. Nattel,et al. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. , 2003, Cardiovascular research.
[67] M. Fishbein,et al. Nonreentrant focal activations in pulmonary veins in canine model of sustained atrial fibrillation. , 2002, American journal of physiology. Heart and circulatory physiology.
[68] Shokei Kim,et al. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. , 1995, The Journal of pharmacology and experimental therapeutics.
[69] José Jalife,et al. Reentry and atrial fibrillation. , 2007, Heart rhythm.
[70] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.
[71] CarloPappone,et al. Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation , 2004 .
[72] S. Nattel,et al. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. , 2006, Cardiovascular research.
[73] T. Doetschman,et al. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. , 2002, The Journal of clinical investigation.
[74] Nassir F Marrouche,et al. Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects. , 2006, Heart rhythm.
[75] A. Hsueh,et al. Activation of Orphan Receptors by the Hormone Relaxin , 2002, Science.
[76] U Schotten,et al. “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat , 2004, Circulation.
[77] A. Becker. How structurally normal are human atria in patients with atrial fibrillation? , 2004, Heart rhythm.
[78] S Nattel,et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. , 1997, Circulation research.
[79] S. Mohiuddin,et al. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. , 2006, American heart journal.